Rchr
J-GLOBAL ID:201301078203684231   Update date: Jun. 10, 2023

Hasegawa Natsumi

Hasegawa Natsumi
Research field  (1): Applied molecular and cellular biology
Research theme for competitive and other funds  (3):
  • 2018 - 2022 ホルモン依存性癌と転写コアクチベーターMED1:診断と治療標的の可能性
  • 2015 - 2018 基本的転写共役因子MED1が担う乳癌の発症と特性
  • 2013 - 2015 転写メディエーターが担う乳癌の発癌と特性
Papers (10):
more...
Lectures and oral presentations  (28):
  • Nuclear receptor binding capacity of MED1 is required for maintaining body temperature at cold environment
    (第40回日本分子生物学会 2017)
  • MED1 regulates mobilization of IL-33 indused type 2 innate lymphoid cells
    (第40回日本分子生物学会 2017)
  • Metabolic markers expressed in mice where MED1 nuclear receptor recognition motifs are defeated
    (第40回日本分子生物学会 2017)
  • Mediator may be involved in transcriptional activation through N-terminal activation domain of GATA1
    (第40回日本分子生物学会 2017)
  • 乳癌発症が遺伝要因と環境要因に依存する可能性-乳癌モデルマウスの検討
    (第38回日本分子生物学会 2016)
more...
Education (1):
  • - 2010 Kobe University Graduate School of Health Sciences
Professional career (1):
  • 修士(保健学) (神戸大学)
Association Membership(s) (1):
Japanese Society of Sonographers
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page